Effect of Mind-Body medicine intervention and intermittent fasting on morbid obesity with dyslipidemia: A Case Report

Abstract

With a rapid increase in morbid obesity, obesity has become a major global health concern with an increased risk of cardiovascular disease and an earlier onset of cardiovascular morbidity. Intermittent fasting (IF) and mind-body interventions are rapidly gaining popularity among the general public and individuals with cardio-metabolic diseases like obesity, diabetes, and hypertension. In this case report, we have assessed the impact of mind-body medicine and intermittent fasting on body weight and dyslipidemia in a morbidly obese patient. A 37-year-old male with morbid obesity (weight: 183 kg) presented with dyslipidemia, breathing difficulty, and sleep disturbance. He underwent mind-body intervention along with intermittent fasting for 20 days. Measurements were taken that included weight, lipid profile, quality of life, Pittsburgh sleep quality index (PSQI), and perceived stress scale (PSS). The patient lost 17 kg of body weight, and his BMI was reduced from 59.1 kg/m2 to 53.7 kg/m2 after 20 days of mind-body medicine intervention with intermittent fasting. Improvement was also observed in the lipid profile, quality of life, sleep quality, and stress level. This case demonstrates that mind-body medicine intervention with intermittent fasting can induce weight loss in a patient with morbid obesity. These findings suggest the potential benefit of integrating mind-body interventions with intermittent fasting regimens to reduce the risk of cardiovascular disease in this population.